Close Menu

NEW YORK (GenomeWeb) – NeoGenomics reported Wednesday morning that fourth quarter revenues grew 12 percent, fueled by strong growth in clinical genetic testing volume and pharmaceutical services.

For the three months ended Dec. 31, 2017, NeoGenomics reported revenues of $67.8 million compared to $60.5 million in the same quarter last year, beating the average analyst estimate of $66.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.